2017: Year in review
It was a year which began for pharmacy in discussion of the fate of codeine, staff pay issues and a review which threatened to destabilise the community pharmacy model And …
Cabinet changes
New Ministers appointed to health, business portfolios Some new faces will be occupying ministerial positions in portfolios of relevance to community pharmacy after Prime Minister Malcolm Turnbull announced his Cabinet …
Pharmacist steps down from NPS role
Lynn Weekes to leave NPS after two decades at the helm The Board of NPS MedicineWise has announced that Dr Lynn Weekes AM has resigned as the organisation’s CEO after …
The division of labour
Opinions and concerns of pharmacy owners and employees now more divergent than ever before There is now a wider gulf in the views of pharmacy owners and employee pharmacists than …
Take three lattes a day for that
Worried about the level of your caffeine intake? Well, new research has indicated that 3-4 cups per day may be doing more good than harm, except during pregnancy UK researchers …
Hit to trading terms
Wholesalers forced to act in the wake of direct distribution defections The recent moves by manufacturers AstraZeneca and Amgen to a direct distribution model are being blamed for driving full-line …
Discharge dispense dilemma
A roundup of research from the recent SHPA Medicines Management 2017 conference, including evidence of poor discharge prescribing of opioids Guidelines are being developed by a local health district …
To indicate or not to indicate?
Study reveals widespread support for including the indication on scripts and medication labels, but concerns have been raised over workload and privacy Adding the indication or purpose of the medication …
Meeting adjourned
Same-sex marriage debate puts the kibosh on annual Guild dinner The Pharmacy Guild of Australia’s annual Parliament House dinner has become an unwitting collateral victim of the debate over same …
Looking for a new product
The manufacturer of testosterone replacement therapy Testogel says it will work with health professionals to fill the void left by the withdrawal of competitor product, Axiron Eli Lilly has this …
